As reported in a research article, over a period of 9 years 9,109 amplatzer devices were implanted, of those 19 were explanted.Five of the devices were explanted due to residual shunt; of these four had evidence of malposition of the device or a new atrial tear and two patients experienced chest pain.The results of the investigation are inconclusive since the devices were not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
Reference manufacturing report number:2135147-2019-00390, 2135147-2019-00389, 2135147-2019-00388, 2135147-2019-00386, 2135147-2019-00383, 2135147-2019-00382, 2135147-2019-00381.It was reported through a research article identifying amplatzer that may be related to explant of devices.Specific patient information is documented as unknown.Details are listed in the attached article, titled explantation of patent foramen ovale closure devices.A study was conducted on the explantation of patent foramen ovale (pfo) devices over a course of nine years.It was found that of the 9,109 amplatzer devices were implanted and 19 were explanted.Five of the devices that were explanted were due to residual shunts.Two of the patients experienced chest pains.There were indications of device malposition or new atrial tear in four of the patients.No patient consequences were reported post procedure.
|